Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy. Participant Population/Primary Condition: Patients admitted to Intensive Care Main Questions Aims to Answer: 1. \- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy? 2. \- How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life? Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons. At the two-year follow-up, the health-related quality of life will be assessed
Study Type
OBSERVATIONAL
Enrollment
300
Percutaneous tracheostomy is a widely used technique in intensive care. It involves creating a passage between the tracheal lumen and the outside, through which a cannula is placed.
Maggiore Hospital Carlo Alberto Pizzardi
Bologna, Italy
RECRUITINGNeck phlegmon
Neck phlegmon in the incisional site
Time frame: 7 days
Intensive Care Stay
Days of ICU stay
Time frame: 1 year
Hospital Stay
Days of hospital stay
Time frame: 1 year
Mortality
30 days mortality
Time frame: 30 days
Health related quality of life
15D instrument
Time frame: 2 years
Dysphagia
Eating Attitude test - EAT-10 questionnaire
Time frame: 2 years
Dysphonia
Voice Handicap Index - VHI-10 questionnaire
Time frame: 2 years
Dyspnoea
Modified Medical Research Council Dyspnea Scale - mMRC-10
Time frame: 2 years
Cough
Leicester Cough Questionnaire - LCQ
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.